Stock Taper
YD Bio Ltd. develops detection and therapeutic technologies, including cancer detection, regenerative ophthalmology, and exosome science, and is based in Taipei, Taiwan, founded in February 2024.

This warrant grants the holder the right to purchase YD Bio Limited shares at a set price before expiration, with its value tied to the company's prospects in cancer detection and regenerative medicine.
| PEER | PRICE | |
|---|---|---|
KZIA | $10.39 | COMPARE |
XBIO | $2.77 | COMPARE |
SNGX | $0.37 | COMPARE |
LEXX | $3.24 | COMPARE |
CMND | $0.80 | COMPARE |
SXTP | $0.96 | COMPARE |